← FDA DRUG APPROVALS

FDA ANDA · ANDA206503

CYANOCOBALAMIN

Sponsor: SOMERSET THERAPS LLC

APPLICATION
ANDA206503
TYPE
ANDA
ORIGINAL APPROVAL
2015-12-11
LATEST ACTION
2020-10-21
ROUTE
INTRAMUSCULAR, SUBCUTANEOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

CYANOCOBALAMINPrescription
CYANOCOBALAMIN 1MG/ML · INJECTABLE · INJECTION

Approval history

2020-10-21Labeling · Supplement 4 · standardAP
2020-10-21Labeling · Supplement 7 · standardAP
2020-10-21Labeling · Supplement 5 · standardAP
2015-12-11UNKNOWN · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →